Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24030700 | 0.99 | KDM4E (0.34) | KDM4EATML3MBTL1MAPK1HTT | |
| SCHEMBL24030171 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL24030173 | 0.95 | KDM4E (0.33) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL24030478 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1MAPK1HTT | |
| SCHEMBL24030336 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1MAPK1HTT | |
| SCHEMBL23471982 | 0.94 | KDM4E (0.32) | KDM4EATML3MBTL1MAPTALDH1A1 | |
| SCHEMBL23471980 | 0.93 | FLT3 (0.32) | KDM4EATML3MBTL1HSD17B10MAPT | |
| SCHEMBL23184818 | 0.92 | KDM4E (0.38) | KDM4EATML3MBTL1MAPK1HTT | |
| SCHEMBL23471999 | 0.90 | FLT3 (0.31) | — | |
| SCHEMBL21716546 | 0.90 | FLT3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LAS1L, ARL1, NAP1L4 | KDM4E 1442/4885ATM 2672/4885L3MBTL1 131/4885 |
| US-20220029107-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | KDM4E 3233/4885ATM 3405/4885L3MBTL1 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.